Related Experiment Video
Updated: Jun 20, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Novel Helicobacter pylori therapeutic targets: the unusual suspects
Megan J Duckworth1, Arinze S Okoli, George L Mendz
1School of Medicine, Sydney, The University of Notre Dame Australia, 160 Oxford Street, Darlinghurst, NSW 2010, Australia. meganjaned@gmail.com
Abstract:
Understanding the current status of the discovery and development of anti-Helicobacter therapies requires an overview of the searches for therapeutic targets performed to date. A summary is given of the very substantial body of work conducted in the quest to find Helicobacter pylori genes that could be suitable candidates for therapeutic intervention. The products of most of these genes perform metabolic functions, and others have roles in growth, cell motility and colonization. The genes identified as potential targets have been organized into three categories according to their degree of characterization. A short description and evaluation is provided of the main candidates in each category. Investigations of potential therapeutic targets have generated a wealth of information about the physiology and genetics of H. pylori, and its interactions with the host, but have yielded little by way of new therapies.
Insights
Discovering new anti-Helicobacter therapies involves identifying therapeutic targets in Helicobacter pylori. Despite extensive research into bacterial genes, few novel treatments have emerged.
Area of Science:
- Microbiology
- Drug Discovery
- Genetics
Background:
- Helicobacter pylori is a significant human pathogen.
- Current anti-Helicobacter therapies face challenges with resistance and efficacy.
- Identifying novel therapeutic targets is crucial for developing new treatments.
Purpose of the Study:
- To review and summarize the research efforts in identifying potential therapeutic targets within Helicobacter pylori.
- To categorize and evaluate the identified genes as potential targets for anti-H. pylori therapies.
Main Methods:
- Comprehensive literature review of studies focused on Helicobacter pylori gene discovery for therapeutic intervention.
- Categorization of identified potential targets based on the extent of their characterization.
- Evaluation of key candidate genes within each category.
Main Results:
- A substantial number of Helicobacter pylori genes have been investigated as potential therapeutic targets.
- Identified targets include genes involved in metabolism, growth, motility, and colonization.
- Candidates were classified into three tiers based on research depth.
Conclusions:
- Extensive research into H. pylori targets has significantly advanced understanding of its physiology, genetics, and host interactions.
- Despite considerable effort, the development of new anti-Helicobacter therapies based on these targets has been limited.
More Related Videos
10:44One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
06:40Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Gastritis II: Pathophysiology
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...